MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iona, S.
Right arrow Articles by Conti, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iona, S.
Right arrow Articles by Conti, M.

Vol. 53, Issue 1, 23-32, January 1998

Characterization of the Rolipram-Sensitive, Cyclic AMP-Specific Phosphodiesterases: Identification and Differential Expression of Immunologically Distinct Forms in the Rat Brain

Saveria Iona, Margherita Cuomo , Tamara Bushnik, Fabio Naro, Claudio Sette, Martin Hess, Earl R. Shelton1 and Marco Conti

Division of Reproductive Biology, Department of Gynecology and Obstetrics, Stanford University Medical Center, Stanford, California 94305-5317 (T.B., F.N., C.S., M.H., M.C.), Institute of Histology and General Embryology, University of Rome, La Sapienza, Rome 00161, Italy (S.I., M.C.), and Syntex Research, Palo Alto, California 94303 (E.R.S.)

To determine the properties of the cAMP-specific, rolipram-sensitive phosphodiesterases (cAMP-PDEs) that are expressed in different organs, monoclonal and polyclonal antibodies were raised against different epitopes present in the cAMP-PDE sequences. Of the several antibodies generated against peptides and fusion proteins, one monoclonal and four polyclonal antibodies recognized both the native cAMP-PDEs as well as the denatured proteins on Western immunoblot analysis. An immunoprecipitation assay demonstrated that these antibodies recognized the recombinant rat PDE4A, PDE4B, and PDE4D proteins with different avidity. The polyclonal antibody K118 and the monoclonal M3S1 were most specific for rat PDE4B and PDE4D forms, respectively, whereas the AC55 antiserum displayed the highest affinity for PDE4A forms. This selectivity was confirmed by Western blot analysis using recombinant rat PDE4A, PDE4B, and PDE4D proteins expressed in a heterologous system. These antibodies were used to characterize the cAMP-PDEs expressed in the rat brain. An immunoblot of extract of cortex and cerebellum demonstrated that at least seven different polypeptides specifically cross-reacted with the different antibodies, indicating that multiple cAMP-PDEs are expressed in this tissue. On the basis of cross-reactivity with PDE4D but not PDE4A or PDE4B antibodies, 93- and 105-kDa PDE4D species were detected in the cortex and cerebellum extract. These forms are different from the 68-kDa PDE4D form expressed in endocrine cells after hormonal stimulation. Although the 93-kDa form was recovered in both the soluble and particulate fractions, the 105-kDa polypeptide was mostly particulate in the cortex and cerebellum extracts. PDE4B forms of 90-87 kDa were recovered in both soluble and particulate compartments of the brain extract. These forms were different from the previously identified PDE4A variants of 110 and 75 kDa. These data demonstrate that the presence of multiple cAMP-PDE genes is translated into cAMP-PDE proteins of different sizes and distinct immunological properties and that multiple variants derived from these cAMP-PDE genes are expressed in different regions of the brain and different subcellular compartments. These immunological tools will be useful to identify different cAMP-PDE forms expressed in organs targeted for pharmacological intervention with PDE4 inhibitors.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
EndocrinologyHome page
R. Zhang, E. Maratos-Flier, and J. S. Flier
Reduced Adiposity and High-Fat Diet-Induced Adipose Inflammation in Mice Deficient for Phosphodiesterase 4B
Endocrinology, July 1, 2009; 150(7): 3076 - 3082.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K.-O. Larsen, B. Lygren, I. Sjaastad, K. A. Krobert, K. Arnkvaern, G. Florholmen, A.-K. R. Larsen, F. O. Levy, K. Tasken, O. H. Skjonsberg, et al.
Diastolic dysfunction in alveolar hypoxia: a role for interleukin-18-mediated increase in protein phosphatase 2A
Cardiovasc Res, October 1, 2008; 80(1): 47 - 54.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Herve, T. Schmitz, D. Evain-Brion, D. Cabrol, M.-J. Leroy, and C. Mehats
The PDE4 Inhibitor Rolipram Prevents NF-{kappa}B Binding Activity and Proinflammatory Cytokine Release in Human Chorionic Cells
J. Immunol., August 1, 2008; 181(3): 2196 - 2202.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Peter, S. L. C. Jin, M. Conti, A. Hatzelmann, and C. Zitt
Differential Expression and Function of Phosphodiesterase 4 (PDE4) Subtypes in Human Primary CD4+ T Cells: Predominant Role of PDE4D
J. Immunol., April 15, 2007; 178(8): 4820 - 4831.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. H. Lee, W. Richter, W. Namkung, K. H. Kim, E. Kim, M. Conti, and M. G. Lee
Dynamic Regulation of Cystic Fibrosis Transmembrane Conductance Regulator by Competitive Interactions of Molecular Adaptors
J. Biol. Chem., April 6, 2007; 282(14): 10414 - 10422.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Schmitz, E. Souil, R. Herve, C. Nicco, F. Batteux, G. Germain, D. Cabrol, D. Evain-Brion, M.-J. Leroy, and C. Mehats
PDE4 Inhibition Prevents Preterm Delivery Induced by an Intrauterine Inflammation
J. Immunol., January 15, 2007; 178(2): 1115 - 1121.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Bajpai, S. E. Fiedler, Z. Huang, S. Vijayaraghavan, G. E. Olson, G. Livera, M. Conti, and D. W. Carr
AKAP3 Selectively Binds PDE4A Isoforms in Bovine Spermatozoa
Biol Reprod, January 1, 2006; 74(1): 109 - 118.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. P. Barnes, G. Livera, P. Huang, C. Sun, W. K. O'Neal, M. Conti, M. J. Stutts, and S. L. Milgram
Phosphodiesterase 4D Forms a cAMP Diffusion Barrier at the Apical Membrane of the Airway Epithelium
J. Biol. Chem., March 4, 2005; 280(9): 7997 - 8003.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
C. MEHATS, S.-L. C. JIN, J. WAHLSTROM, E. LAW, D. T. UMETSU, and M. CONTI
PDE4D plays a critical role in the control of airway smooth muscle contraction
FASEB J, October 1, 2003; 17(13): 1831 - 1841.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
V. De Arcangelis, D. Coletti, M. Conti, M. Lagarde, M. Molinaro, S. Adamo, G. Nemoz, and F. Naro
IGF-I-induced Differentiation of L6 Myogenic Cells Requires the Activity of cAMP-Phosphodiesterase
Mol. Biol. Cell, April 1, 2003; 14(4): 1392 - 1404.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
F. J. Richard, A. Tsafriri, and M. Conti
Role of Phosphodiesterase Type 3A in Rat Oocyte Maturation
Biol Reprod, November 1, 2001; 65(5): 1444 - 1451.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Hansen, S.-L. C. Jin, D. T. Umetsu, and M. Conti
Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D
PNAS, June 6, 2000; 97(12): 6751 - 6756.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. B. Herman, D. M. Juilfs, E. B. Fauman, P. Juneau, and J. P. Menetski
Analysis of a Mutation in Phosphodiesterase Type 4 that Alters Both Inhibitor Activity and Nucleotide Selectivity
Mol. Pharmacol., May 1, 2000; 57(5): 991 - 999.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
N. Oki, S.-I. Takahashi, H. Hidaka, and M. Conti
Short Term Feedback Regulation of cAMP in FRTL-5 Thyroid Cells. ROLE OF PDE4D3 PHOSPHODIESTERASE ACTIVATION
J. Biol. Chem., April 6, 2000; 275(15): 10831 - 10837.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Méhats, G. Tanguy, B. Paris, B. Robert, N. Pernin, F. Ferré, and M.-J. Leroy
Pregnancy Induces a Modulation of the cAMP Phosphodiesterase 4-Conformers Ratio in Human Myometrium: Consequences for the Utero-Relaxant Effect of PDE4-Selective Inhibitors
J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 817 - 823.
[Abstract] [Full Text]


Home page
Mol. Biol. CellHome page
F. Naro, C. Sette, E. Vicini, V. De Arcangelis, M. Grange, M. Conti, M. Lagarde, M. Molinaro, S. Adamo, and G. Némoz
Involvement of Type 4 cAMP-Phosphodiesterase in the Myogenic Differentiation of L6 Cells
Mol. Biol. Cell, December 1, 1999; 10(12): 4355 - 4367.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
S.-L. C. Jin, F. J. Richard, W.-P. Kuo, A. J. D'Ercole, and M. Conti
Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice
PNAS, October 12, 1999; 96(21): 11998 - 12003.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Lim, G. Pahlke, and M. Conti
Activation of the cAMP-specific Phosphodiesterase PDE4D3 by Phosphorylation. IDENTIFICATION AND FUNCTION OF AN INHIBITORY DOMAIN
J. Biol. Chem., July 9, 1999; 274(28): 19677 - 19685.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Méhats, G. Tanguy, E. Dallot, B. Robert, R. Rebourcet, F. Ferré, and M. J. Leroy
Selective Up-Regulation of Phosphodiesterase-4 Cyclic Adenosine 3',5'-Monophosphate (cAMP)-Specific Phosphodiesterase Variants by Elevated cAMP Content in Human Myometrial Cells in Culture
Endocrinology, July 1, 1999; 140(7): 3228 - 3237.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. Salanova, S.-Y. Chun, S. Iona, C. Puri, M. Stefanini, and M. Conti
Type 4 Cyclic Adenosine Monophosphate-Specific Phosphodiesterases Are Expressed in Discrete Subcellular Compartments during Rat Spermiogenesis
Endocrinology, May 1, 1999; 140(5): 2297 - 2306.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
M. Takahashi, R. Terwilliger, C. Lane, P. S. Mezes, M. Conti, and R. S. Duman
Chronic Antidepressant Administration Increases the Expression of cAMP-Specific Phosphodiesterase 4A and 4B Isoforms
J. Neurosci., January 15, 1999; 19(2): 610 - 618.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
K. L. O'Connor, L. M. Shaw, and A. M. Mercurio
Release of cAMP Gating by the alpha 6beta 4 Integrin Stimulates Lamellae Formation and the Chemotactic Migration of Invasive Carcinoma Cells
J. Cell Biol., December 14, 1998; 143(6): 1749 - 1760.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S.-L. C. Jin, T. Bushnik, L. Lan, and M. Conti
Subcellular Localization of Rolipram-sensitive, cAMP-specific Phosphodiesterases. DIFFERENTIAL TARGETING AND ACTIVATION OF THE SPLICING VARIANTS DERIVED FROM THE PDE4D GENE
J. Biol. Chem., July 31, 1998; 273(31): 19672 - 19678.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. A. Tasken, P. Collas, W. A. Kemmner, O. Witczak, M. Conti, and K. Tasken
Phosphodiesterase 4D and Protein Kinase A Type II Constitute a Signaling Unit in the Centrosomal Area
J. Biol. Chem., June 15, 2001; 276(25): 21999 - 22002.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Verde, G. Pahlke, M. Salanova, G. Zhang, S. Wang, D. Coletti, J. Onuffer, S.-L. C. Jin, and M. Conti
Myomegalin Is a Novel Protein of the Golgi/Centrosome That Interacts with a Cyclic Nucleotide Phosphodiesterase
J. Biol. Chem., March 30, 2001; 276(14): 11189 - 11198.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics